{"nctId":"NCT00623623","briefTitle":"STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction","startDateStruct":{"date":"2008-03-01","type":"ACTUAL"},"conditions":["Myocardial Infarction"],"count":1899,"armGroups":[{"label":"Tenecteplase","type":"EXPERIMENTAL","interventionNames":["Drug: enoxaparin","Procedure: catheterisation","Drug: tenecteplase","Drug: clopidogrel"]},{"label":"primary PCI","type":"OTHER","interventionNames":["Procedure: primary PCI"]}],"interventions":[{"name":"primary PCI","otherNames":[]},{"name":"enoxaparin","otherNames":[]},{"name":"catheterisation","otherNames":[]},{"name":"tenecteplase","otherNames":[]},{"name":"clopidogrel","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\n1. Age equal or greater than 18 years\n2. Onset of symptoms \\< 3 hours prior to randomisation 3.12-lead ECG indicative of an acute STEMI\n\n4.Informed consent received\n\nExclusion criteria:\n\nMedical history, procedures, medication administration or the presence of factors that would in general predispose to bleeding events and/or the inability to evaluate the study primary endpoint","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Patients With All-cause Mortality, Cardiogenic Shock, Congestive Heart Failure and Recurrent Myocardial Infarction Within 30 Days for FAS.","description":"The number of observed patients with all-cause mortality, cardiogenic shock, congestive heart failure (CHF) and recurrent myocardial infarction within 30 days was reported for full analysis set (FAS).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"116","spread":null},{"groupId":"OG001","value":"135","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With All Cause Mortality","description":"This is a key secondary endpoint. The number of observed patients with all cause mortality within 30 days was reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Cardiac Mortality","description":"This is a key secondary endpoint. The number of observed patients with cardiac mortality within 30 days was reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Cardiogenic Shock","description":"This is a key secondary endpoint. The number of observed patients with cardiogenic shock within 30 days was reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41","spread":null},{"groupId":"OG001","value":"56","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Congestive Heart Failure (CHF)","description":"This is a key secondary endpoint. The number of observed patients with congestive heart failure (CHF) within 30 days was reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"72","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Recurrent Myocardial Infarction (Reinfarction)","description":"This is a key secondary endpoint. The number of observed patients with recurrent myocardial infarction (reinfarction) within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Rehospitalisation for Cardiac Reasons","description":"This is a key secondary endpoint. The number of observed patients with rehospitalisation for cardiac reasons within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null},{"groupId":"OG001","value":"41","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Rehospitalisation for Non-cardiac Reasons","description":"This is a key secondary endpoint. The number of observed patients with rehospitalisation for non-cardiac reasons within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Serious Repeat Target Vessel Revascularization","description":"This is a key secondary endpoint. The number of observed patients with serious repeat target vessel revascularization within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With All Cause Death and Shock","description":"This is a key secondary endpoint. The number of observed patients with all cause death and shock within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"73","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With All Cause Death and Shock and CHF","description":"This is a key secondary endpoint. The number of observed patients with all cause death and shock and CHF within 30 days was reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"123","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With All Cause Death and Shock and Reinfarction","description":"This is a key secondary endpoint. The number of observed patients with all cause death and shock and reinfarction within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77","spread":null},{"groupId":"OG001","value":"85","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Total Fatal Stroke","description":"This is a key secondary endpoint. The number of observed patients with total fatal stroke within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Total Disabling Stroke","description":"This is a key secondary endpoint. The number of observed patients with total disabling stroke within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Total Non-disabling Stroke","description":"This is a key secondary endpoint. The number of observed patients with total non-disabling stroke within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Intracranial Haemorrhage","description":"This is a key secondary endpoint. The number of observed patients with intracranial haemorrhage within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Ischaemic Stroke","description":"This is a key secondary endpoint. The number of observed patients with ischaemic stroke within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Total Stroke (All Types)","description":"This is a key secondary endpoint. The number of observed patients with total stroke (all types) within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Major Non-intracranial Bleeds Including Blood Transfusions","description":"This is a key secondary endpoint. The number of observed patients with major non-intracranial bleeds including blood transfusions within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Minor Non-intracranial Bleeds","description":"This is a key secondary endpoint. The number of observed patients with minor non-intracranial bleeds within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"206","spread":null},{"groupId":"OG001","value":"191","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Total Non-intracranial Bleeds","description":"This is a key secondary endpoint. The number of observed patients with total non-intracranial bleeds within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"267","spread":null},{"groupId":"OG001","value":"236","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Serious Resuscitated Ventricular Fibrillation","description":"This is a key secondary endpoint. The number of observed patients with serious resuscitated ventricular fibrillation within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"38","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Serious Resuscitated Ventricular Fibrillation in Association With Invasive Procedures","description":"This is a key secondary endpoint. The number of observed patients with serious resuscitated ventricular fibrillation in association with invasive procedures (occurring at any time during catheterisation or urgent/elective PCI) within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With All Cause Death and Non-fatal Stroke","description":"This is a key secondary endpoint. The number of observed patients with all cause death and non-fatal stroke within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"43","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With All Cause Death and Shock and CHF and Reinfarction and Disabling Stroke","description":"This is a key secondary endpoint. The number of observed patients with all cause death and shock and CHF and reinfarction and disabling stroke within 30 days was reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"117","spread":null},{"groupId":"OG001","value":"135","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":146,"n":949},"commonTop":[]}}}